IDEXX Laboratories, Inc. (IDXX)
538.99
-6.17
(-1.13%)
USD |
NASDAQ |
Sep 02, 16:00
538.89
-0.10
(-0.02%)
After-Hours: 20:00
IDEXX Laboratories Enterprise Value : 43.41B for Sept. 2, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 02, 2026 | 43.41B |
| September 01, 2026 | 43.90B |
| August 31, 2026 | 44.81B |
| August 28, 2026 | 44.67B |
| August 27, 2026 | 43.89B |
| August 26, 2026 | 44.55B |
| August 25, 2026 | 44.28B |
| August 24, 2026 | 45.03B |
| August 21, 2026 | 44.83B |
| August 20, 2026 | 43.95B |
| August 19, 2026 | 45.24B |
| August 18, 2026 | 44.54B |
| August 17, 2026 | 43.97B |
| August 14, 2026 | 44.36B |
| August 13, 2026 | 45.62B |
| August 12, 2026 | 45.90B |
| August 11, 2026 | 47.17B |
| August 10, 2026 | 47.89B |
| August 07, 2026 | 47.17B |
| August 06, 2026 | 47.43B |
| August 05, 2026 | 47.02B |
| August 04, 2026 | 47.28B |
| August 03, 2026 | 45.69B |
| July 31, 2026 | 45.00B |
| July 30, 2026 | 44.97B |
| Date | Value |
|---|---|
| July 29, 2026 | 45.84B |
| July 28, 2026 | 45.82B |
| July 27, 2026 | 44.77B |
| July 24, 2026 | 43.83B |
| July 23, 2026 | 43.44B |
| July 22, 2026 | 43.89B |
| July 21, 2026 | 44.47B |
| July 20, 2026 | 45.37B |
| July 17, 2026 | 45.66B |
| July 16, 2026 | 46.34B |
| July 15, 2026 | 44.83B |
| July 14, 2026 | 43.54B |
| July 13, 2026 | 45.40B |
| July 10, 2026 | 45.35B |
| July 09, 2026 | 44.96B |
| July 08, 2026 | 44.73B |
| July 07, 2026 | 45.88B |
| July 06, 2026 | 45.46B |
| July 02, 2026 | 44.90B |
| July 01, 2026 | 43.30B |
| June 30, 2026 | 42.42B |
| June 29, 2026 | 43.37B |
| June 26, 2026 | 44.61B |
| June 25, 2026 | 44.88B |
| June 24, 2026 | 44.42B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| DexCom, Inc. | 33.30B |
| Intuitive Surgical, Inc. | 126.49B |
| Abbott Laboratories | 218.81B |
| Align Technology, Inc. | 10.36B |
| Integra LifeSciences Holdings Corp. | 3.082B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 338.41M |
| Revenue (Quarterly) | 1.217B |
| Total Expenses (Quarterly) | 878.17M |
| EPS Diluted (Quarterly) | 4.267 |
| Gross Profit Margin (Quarterly) | 64.07% |
| Profit Margin (Quarterly) | 27.82% |
| Earnings Yield | 2.64% |
| Operating Earnings Yield | 3.39% |
| Normalized Earnings Yield | 2.631 |